Trial Profile

Effects of Lomitapide on Carotid and Aortic Atherosclerosis in Patients Treated With Lomitapide in Usual Care (CAPTURE)

Status: Withdrawn prior to enrolment

Phase of Trial: Phase IV

Latest Information Update: 18 Dec 2017

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs Lomitapide (Primary)
Indications Hypercholesterolaemia
Focus Therapeutic Use
Acronyms CAPTURE
Sponsors Aegerion Pharmaceuticals

Most Recent Events

13 Dec 2017 Planned primary completion date changed from 1 Apr 2021 to 1 Dec 2018.
13 Dec 2017 Planned initiation date changed from 1 Apr 2015 to 1 Jun 2015.
13 Dec 2017 Status changed from not yet recruiting to withdrawn prior to enrolment.

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com